New Partnership in the UK and Ireland

Helsinki – June 14, 2021 – MVision AI is excited to announce partnership with the UK and Ireland-based distributor, Xiel ltd. Xiel will be distributing MVision AI’s high-quality, segmentation services throughout the UK and Ireland region.

“I am delighted Xiel has officially partnered with MVision, a company leading the way in AI technology and one we have followed closely for a number of years. AI is a buzz word in our sector at the moment and we are very excited about working with MVision to integrate their leading technology into Radiotherapy departments in the UK and Ireland”, said Jack Knight, Managing Director, Xiel Ltd

This has a high impact on RT treatment because, according to Cancer Research UK, the time between the urgent referral and treatment process can take up to 62 days. Thanks to Xiel’s distribution of MVision AI’s segmentation software, oncologists will be able to receive consistent, cancer radiotherapy treatment planning. MVision’s cutting-edge, segmentation solutions can help improve the efficiency of cancer patient’s radiotherapy.

MVsion’s CEO and co-founder, Mahmudul Hasan, highlighted his delight in this new partnership, stating that, “We have been working on MVision’s state-of-the-art segmentation services for the last three years. A growing number of hospitals have incorporated our services into their radiation oncology departments. Radiation oncologists have found our solutions to be essential, while improving the speed of service to their patients. We look forward to doing the same for UK patients, as our breakthrough solution reaches the UK and Ireland with the help of Xiel.”

If you are interested in learning more about Xiel’s impactful distribution, check out their informative, company website and professional LinkedIn profile.

For more information on our services, contact MVision AI

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Email: info (at)


+358 40 500 7915; pr (at)

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts


World Kidney Cancer Day 2024: “Listen”

World Kidney Cancer Day is observed every year on the second Thursday of June. “Listening” is this year’s theme, which refers to the benefits of shared decision making, patient’s empowerment to seek a second opinion and creating awareness around misinformation and how to check if sources are reliable (1). More…



MVision AI Appoints Antti Pirskanen as New Chief Financial Officer

Helsinki, Finland – June 14, 2024 – MVision AI, a pioneering company in the development of innovative AI solutions for radiation oncology is pleased to announce the appointment of Antti Pirskanen as its new Chief Financial Officer (CFO). Antti will assume his responsibilities immediately, bringing extensive expertise in financial management…

Press Releases


MVision AI Receives MFDS Approval and Market Authorization for South Korea

HELSINKI, Finland – June 14, 2024 MVision AI is pleased to announce that our application for MVision AI Segmentation (Contour+) in South Korea has been accepted by the Ministry of Food and Drug Safety (MFDS) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation…

Press Releases